15

Oct

2025

15:00

BST

16:00

CEST

Webinar

Optimising Persistent AF Ablation: Precision, Lesion Integrity, and Workflow Efficiency

Average (ratings)
No ratings
Your rating

Overview

Persistent AF ablation demands precision, lesion integrity, and an efficient workflow. This expert-led webinar brings together leading electrophysiologists to share the latest innovations, clincial evidence, and real-world strategies driving better outcomes.

Prof Serge Boveda will set the scene with Setting the Stage: Innovations and Insights in AF Ablation, before unveiling key results from ADVANTAGE AF Phase I & II: Safety, Efficacy, and Beyond. Prof Daniel Scherr will take you inside a recorded case, Persistent AF and PWA Strategy: From Mapping to Optimisation, demonstrating how FARAVIEW™ supports lesion delivery mastery in the clinical workflow. Prof Christian Sohns will then spotlight Rethinking Lesion Depth: A New Frontier in Focal Ablation Technology.

The session closes with The Final Pulse: Debating Clinical Decisions in Persistent AF,  a dynamic Q&A where faculty will tackle your most pressing questions.

Don’t miss this opportunity to enhance your approach to persistent AF ablation and gain actionable insights from world-class experts.

EP-2268204-AA

FARAPOINT™ PFA Catheter is pending CE mark. Not available for sales. 

FARAPULSE™ PFA Platform - CE 0459. Use of FARAPULSE™ for treatment of Persistent AF is pending CE Mark.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France. ©2025 Boston Scientific Corporation or its affiliates. All rights reserved.
 

Faculty:


Serge Boveda

Serge Boveda


Daniel Scherr

Daniel Scherr


Christian Sohns

Christian Sohns

This webinar is supported by Boston Scientific

Agenda

Introduction

Prof Serge Boveda

ADVANTAGE AF Phase I and II: Safety, Efficacy, and Beyond

Prof Serge Boveda

Recorded Case Presentation: Persistent AF and PWA Strategy: From Mapping to Optimisation

Prof Daniel Scherr

Rethinking Lesion Depth: A New Frontier in Focal Ablation Technology

Prof Christian Sohns

Q&A and Closing Summary

Prof Serge Boveda

Target Audience

  • Cardiologist - Non-invasive
  • Cardiothoracic Surgeon
  • Cardiovascular Scientist
  • Electrophysiologist
  • Healthcare Professional in training
  • Heart Failure Specialist
  • Interventional Cardiologist
  • Nurse/Nurse Practitioner
  • Paediatric Cardiologist
  • Primary Care Physician
  • Cardiac Technician
  • Cardiac Physiologist
  • Healthcare Administration

Faculty Biographies


Serge Boveda

Serge Boveda

Prof Dr Serge Boveda, Clinique Pasteur, Toulouse, FRProf Dr Boveda (MD, PhD, FESC, FEHRA) is a specialist in cardiovascular diseases and the interventional treatment of cardiac arrhythmias since 1994.

View full profile

Daniel Scherr

Daniel Scherr

Prof Daniel Scherr is an Associate Professor in the Clinical Department of Cardiology at the Medical University of Graz, Graz, Austria. His research interests include cardiology, electrophysiology, telemedicine and intensive care.

View full profile

Christian Sohns

Christian Sohns

In 2008 Professor Sohns was a Resident in the Department of Cardiology and Pneumology at the Georg-August University in Göttingen, in 2015, Professor Sohns became senior physician specializing in electrophysiology in the cardiology dep

View full profile